Background
==========

Determination of stem cell behavior *in vivo* is a major challenge in the study of normal and leukemic hematopoiesis. This requires dynamic tracking of cells *in vitro* in cell culture based assays and in vivo in transplantation models. Most of the existing methods for tracking cells are based on gene transfers that might modulate the engraftment and/or leukemogenicity of transplanted cells \[[@B1]\]. In order to evaluate the use of alternative gene-transfer free methods, we tested *in vitro* labeling of leukemic cells using nanodiamonds (ND). NDs have become the most promising candidate in recent years due to their excellent biocompatibility, chemical stability, scalability, fluorescent properties and easy functionalization \[[@B2]\].

Materials and methods
=====================

Human leukemia cell lines HL60 and K562, grown in RPMI1640 medium containing 10% fetal bovine serum, were incubated with different concentrations of 6nm nanodiamond - phosphate buffered saline- suspension. Cell viability was assessed using Trypan blue exclusion method at 24h and 72h of incubation. Flow cytometry was performed after 24h and 72 h of incubation to detect the scatter properties of cells. Confocal fluorescence microscopy was performed to detect nanodiamonds after 24 hr incubation.

Results
=======

No significant cytotoxicity was observed after incubation of HL60 and K562 cells with up to 10ug/ml ND. Flow cytometry of cells incubated with ND revealed a dose-dependent increase in the side scatter properties of the cells (Figure [1](#F1){ref-type="fig"}). Confocal microscopy revealed aggregates of fluorescent ND particles in the cytoplasm of both HL60 and K562 cells confirming the uptake of ND. ND+ K562 cells were sorted using the flow cytometer and cultured. ND+ cells were detected up to 5 days post sorting, indicating good retention of these particles
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Conclusions
===========

Our experiments demonstrate for the first time that nanodiamonds can be used successfully in labeling and *in vitro* tracking of leukemic cell lines using flow cytometry and confocal fluorescence imaging, making them a potential candidate for studying *in vivo* tracking in xenograft or syngenic mouse models of leukemia.
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